Aevi Genomic Medicine Competitors and Similar CompaniesClear all
Aevi Genomic Medicine's competitors and similar companies include AnGes, Lexicon Pharmaceuticals and Intellia Therapeutics.
 AnGes AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine. |  Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology. |  Intellia Therapeutics Intellia Therapeutics is a genome editing company that caters to the biotechnology industry. | ||
Founding Date | Founding Date 2000 | Founding Date 1999 | Founding Date 1995 | Founding Date 2014 |
Type | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Wayne, US HQ San Francisco, US | Locations Ibaraki, JP HQ Fujisawa, JP Ibaraki, JP Kawasaki, JP Minato City, JP Bethesda, US | Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more | Locations Cambridge, US HQ |
Employees | Employees 1418% decrease | Employees 5562% decrease | Employees 20216% increase | Employees 40323% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 78.3 m | Valuation ($) 737.4 m | Valuation ($) 1.7 b |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥874.1m (FY, 2025) | Revenue (est.) $49.8m (FY, 2025) | Revenue (est.) $67.7m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥499.9m (FY, 2025) | Cost of goods $274k (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ¥374.2m (FY, 2025) | Gross profit $49.5m (FY, 2025) | Gross profit N/A |
Net income | Net income ($30.8m) (FY, 2018) | Net income (¥5.1b) (FY, 2025) | Net income ($50.3m) (FY, 2025) | Net income ($412.7m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 7m | Total funding raised N/A | Total funding raised $ 244.7m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
AnGes
HQ
Ibaraki, JP
Employees
55
AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine.
View companyLexicon Pharmaceuticals
HQ
The Woodlands, US
Employees
202↑ 16% increase
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
View companyIntellia Therapeutics
HQ
Cambridge, US
Employees
403↓ 23% decrease
Intellia Therapeutics is a genome editing company that caters to the biotechnology industry.
View company